These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21355884)

  • 1. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.
    Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V;
    Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients.
    Tavira B; Gómez J; Díaz-Corte C; Llobet L; Ruiz-Pesini E; Ortega F; Coto E
    Gene; 2014 Mar; 538(1):195-8. PubMed ID: 24445060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-onset diabetes after transplantation: drug-related risk factors.
    Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
    Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation.
    Kim YG; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim SK; Kim YH
    Transplantation; 2012 May; 93(9):900-7. PubMed ID: 22377791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
    Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
    Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
    Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of new onset of diabetes after transplantation in stable renal recipients.
    Shehab-Eldin W; Shoker A
    Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.
    Chen Y; Sampaio MS; Yang JW; Min D; Hutchinson IV
    Transplantation; 2012 Feb; 93(3):325-30. PubMed ID: 22234350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers.
    Fougeray S; Loriot MA; Nicaud V; Legendre C; Thervet E; Pallet N
    Transplant Proc; 2011 Nov; 43(9):3418-22. PubMed ID: 22099811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
    Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
    Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of new onset diabetes after renal transplantation.
    Joss N; Staatz CE; Thomson AH; Jardine AG
    Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.
    Ruderman I; Masterson R; Yates C; Gorelik A; Cohney SJ; Walker RG
    Nephrology (Carlton); 2012 Jan; 17(1):89-96. PubMed ID: 21854501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience.
    Al-Ghareeb SM; El-Agroudy AE; Al Arrayed SM; Al Arrayed A; Alhellow HA
    Exp Clin Transplant; 2012 Oct; 10(5):458-65. PubMed ID: 22943190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.